CLINICAL TRIALS PROFILE FOR PROTAMINE ZINC INSULIN
✉ Email this page to a colleague
All Clinical Trials for Protamine Zinc Insulin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00348231 ↗ | Jikei Optimal Insulin Therapy in Type 2 Diabetes | Unknown status | Novo Nordisk A/S | N/A | 2004-11-01 | The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection. |
NCT00348231 ↗ | Jikei Optimal Insulin Therapy in Type 2 Diabetes | Unknown status | Jikei University School of Medicine | N/A | 2004-11-01 | The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection. |
NCT00474045 ↗ | Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes | Completed | Novo Nordisk A/S | Phase 3 | 2007-05-01 | This trial is conducted in Africa, Europe, North and South America and Oceania. The aim of this trial is to compare the effect and safety on blood glucose control in pregnant women with type 1 diabetes of a modern insulin analogue (insulin detemir) and human insulin (NPH insulin) given as long-acting insulin in combination with a short-acting insulin (insulin aspart). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Protamine Zinc Insulin
Condition Name
Clinical Trial Locations for Protamine Zinc Insulin
Trials by Country
Clinical Trial Progress for Protamine Zinc Insulin
Clinical Trial Phase
Clinical Trial Sponsors for Protamine Zinc Insulin
Sponsor Name